Communications
1994, 50, 4439; alternative Rh catalysts: c) K. Inagaki, K. Nozaki,
[15] For recent applications of imidazolines in asymmetric catalysis,
see for example, a) F. Menges, M. Neuburger, A. Pfaltz, Org.
Lett. 2002, 4, 4713; b) C. A. Busacca, D. Grossbach, R. C. So,
E. M. OꢀBrien, E. M. Spinelli, Org. Lett. 2003, 5, 595; c) S. Bhor,
G. Anilkumar, M. K. Tse, M. Klawonn, C. Dobler, B. Bitterlich,
A. Grotevendt, M. Beller, Org. Lett. 2005, 7, 3393; d) K. Ma, J.
You, Chem. Eur. J. 2007, 13, 1863; e) T. Arai, T. Mizukami, A.
Yanagisawa, Org. Lett. 2007, 9, 1145; f) S. Enthaler, B. Hage-
mann, S. Bhor, G. Anilkumar, M. K. Tse, B. Bitterlich, K. Junge,
G. Erre, M. Beller, Adv. Synth. Catal. 2007, 349, 853; g) T. Arai,
N. Yokoyama, A. Yanagisawa, Chem. Eur. J. 2008, 14, 2052;
h) Z.-q. Xin, D. F. Fischer, R. Peters, Synlett 2008, 1495; i) S.
Nakamura, K. Hyodo, Y. Nakamura, N. Shibata, T. Toru, Adv.
Synth. Catal. 2008, 350, 1443; j) T. Arai, N. Yokoyama, Angew.
Chem. 2008, 120, 5067; Angew. Chem. Int. Ed. 2008, 47, 4989.
[16] ortho-Substituted phenyl groups were not well tolerated and
moderate enantioselectivity was obtained, e.g.: o-FC6H4:
57% ee, 1-naphthyl: 50% ee.
H. Takaya, Synlett 1997, 119; d) Y. Motoyama, Y. Koga, K.
Kobayashi, K. Aoki, H. Nishiyama, Chem. Eur. J. 2002, 8, 2968;
for previous non-enantioselective studies with Ru and Rh
catalysts, see: e) T. Naota, H. Taki, M. Mizuno, S.-I. Murahashi,
J. Am. Chem. Soc. 1989, 111, 5954; f) S. Paganelli, A. Schionato,
C. Botteghi, Tetrahedron Lett. 1991, 32, 2807; Ir-catalyst: g) D.
Carmona, J. Ferrer, M. Lorenzo, F. J. Lahoz, I. T. Dobrinovitch,
L. A. Oro, Eur. J. Inorg. Chem. 2005, 1657.
[6] a) M. A. Stark, C. J. Richards, Tetrahedron Lett. 1997, 38, 5881;
b) M. A. Stark, G. Jones, C. J. Richards, Organometallics 2000,
19, 1282.
[7] a) K. Takenaka, Y. Uozumi, Org. Lett. 2004, 6, 1833; b) K.
Takenaka, M. Minakawa, Y. Uozumi, J. Am. Chem. Soc. 2005,
127, 12273; alternative PdII catalysts: c) C. Mazet, L. H. Gade,
Chem. Eur. J. 2003, 9, 1759; PtII catalyst: d) A. J. Blacker, M. L.
Clarke, M. S. Loft, M. F. Mahon, J. M. J. Williams, Organo-
metallics 1999, 18, 2867.
[8] M. S. Taylor, D. N. Zalatan, A. M. Lerchner, E. N. Jacobsen, J.
Am. Chem. Soc. 2005, 127, 1313.
[17] CCDC 695750 contains the supplementary crystallographic data
for this paper. These data can be obtained free of charge from
The Cambridge Crystallographic Data Centre via www.ccdc.
a chiral stationary phase subsequently confirmed that the major
enantiomer of 2Cda was investigated.
[9] M. S. Taylor, E. N. Jacobsen, J. Am. Chem. Soc. 2003, 125, 11204.
[10] Recent reviews about palladacycles: a) W. A. Herrmann,
V. P. W. Bohm, C. P. Reisinger, J. Organomet. Chem. 1999, 576,
23; b) M. Albrecht, G. van Koten, Angew. Chem. 2001, 113,
3866; Angew. Chem. Int. Ed. 2001, 40, 3750; c) J. Dupont, M.
Pfeffer, J. Spencer, Eur. J. Inorg. Chem. 2001, 1917; d) R. B.
Bedford, Chem. Commun. 2003, 1787; e) M. E. van der Boom,
D. Milstein, Chem. Rev. 2003, 103, 1759; f) J. T. Singleton,
Tetrahedron 2003, 59, 1837; g) F. Bellina, A. Carpita, R. Rossi,
Synthesis 2004, 2419; h) R. B. Bedford, C. S. J. Cazin, D. Holder,
Coord. Chem. Rev. 2004, 248, 2283; i) I. Omae, Coord. Chem.
Rev. 2004, 248, 995; j) I. P. Beletskaya, A. V. Cheprakov, J.
Organomet. Chem. 2004, 689, 4055; k) J. Dupont, C. S. Consorti,
J. Spencer, Chem. Rev. 2005, 105, 2527. For pioneering work
using planar-chiral palladacycles for aza-Claisen rearrange-
ments, see: l) T. K. Hollis, L. E. Overman, J. Organomet.
Chem. 1999, 576, 290; m) C. E. Anderson, L. E. Overman, J.
Am. Chem. Soc. 2003, 125, 12412; n) L. E. Overman, C. E.
Owen, M. M. Pavan, C. J. Richards, Org. Lett. 2003, 5, 1809.
[11] a) N. Strꢂter, W. N. Lipscomb, T. Klabunde, B. Krebs, Angew.
Chem. 1996, 108, 2158; Angew. Chem. Int. Ed. Engl. 1996, 35,
2024; b) D. E. Wilcox, Chem. Rev. 1996, 96, 2435; c) H.
Steinhagen, G. Helmchen, Angew. Chem. 1996, 108, 2489;
Angew. Chem. Int. Ed. Engl. 1996, 35, 2339.
[12] Reviews: a) E. K. van den Beuken, B. L. Feringa, Tetrahedron
1998, 54, 12985; b) M. Shibasaki, S. Matsunaga, Chem. Soc. Rev.
2006, 35, 269; for selected recent examples, see: c) C. Mazet,
E. N. Jacobsen, Angew. Chem. 2008, 120, 1786; Angew. Chem.
Int. Ed. 2008, 47, 1762; d) S. Handa, K. Nagawa, Y. Sohtome, S.
Matsunaga, M. Shibasaki, Angew. Chem. 2008, 120, 3274;
Angew. Chem. Int. Ed. 2008, 47, 3230; e) S. Takizawa, T.
Katayama, H. Sasai, Chem. Commun. 2008, 35, 4113.
[13] a) S. Jautze, P. Seiler, R. Peters, Angew. Chem. 2007, 119, 1282;
Angew. Chem. Int. Ed. 2007, 46, 1260; b) S. Jautze, P. Seiler, R.
Peters, Chem. Eur. J. 2008, 14, 1430.
[14] For the first preparation of chiral ferrocenyl imidazolines, see:
a) R. Peters, D. F. Fischer, Org. Lett. 2005, 7, 4137; b) R. Peters,
Z.-q. Xin, D. F. Fischer, W. B. Schweizer, Organometallics 2006,
25, 2917.
1
[18] Complexation of MVK was not detected by H NMR spectros-
copy, indicating that such a complex is arguably too short-lived
on the NMR timescale.
[19] a) M. E. Weiss, D. F. Fischer, Z.-q. Xin, S. Jautze, W. B.
Schweizer, R. Peters, Angew. Chem. 2006, 118, 5823; Angew.
Chem. Int. Ed. 2006, 45, 5694; Angew. Chem. 2006, 118, 5823; for
the catalytic asymmetric formation of quaternary stereocenters
by aza-Claisen rearrangements, see: b) D. F. Fischer, Z.-q. Xin,
R. Peters, Angew. Chem. 2007, 119, 7848; Angew. Chem. Int. Ed.
2007, 46, 7704.
[20] The corresponding ferrocenyl imidazoline monopalladacycle
complex with a C5Ph5 spectator ligand resulted in ca. À50% ee
under identical reaction conditions.
[21] A b-hydride elimination would result in the formation of Pd0
species which are usually not stable as palladacycles and form
“naked” Pd0 (see Ref. [10]). The monopalladacycle formed by
decomplexation of one Pd0 would lead to a competing pathway
providing preferentially the other enantiomer.
[22] The optimized conditions for a-aryl-substituted a-cyano acetates
are not useful for a-alkyl-substituted substrates and result in
poor enantioselectivity. Current studies are therefore directed
toward the extension to this substrate class.
[23] One referee proposed a reversible Michael addition step as
mechanistic alternative to explain the enantioselectivity. How-
ever, our data can almost rule out such a scenario. If the step I to
II in Scheme 1 is reversible, lower ee values should be obtained
with an increasing amount of acetic acid, since in that case the
lifetime of II would be reduced. Before the equilibrium would be
reached (in that scenario necessary for high ee), the intermediate
would be trapped. For that reason we can also rule out that
protonation would be the enantioselectivity-determining step.
Cross experiments in which 2Ada and 2Cdb were treated with
2 mol% bispalladacycle catalyst at room temperature revealed
overall irreversibility as the formation of 2Adb and 2Cda could
not be detected by HPLC or NMR spectroscopy.
ꢀ 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Angew. Chem. Int. Ed. 2008, 47, 9284 –9288